Related Experiment Video
Updated: Mar 17, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Acceptability of Robot Assistant in Management of Type 1 Diabetes in Children
Majid A Al-Taee1, Ritika Kapoor2, Christopher Garrett3
11 Department of Electrical Engineering and Electronics, University of Liverpool , Liverpool, United Kingdom .
Background:
To find out whether children with type 1 diabetes accept a humanoid robot as an assistant in their diabetes management. In particular, the study aims to determine how the patients feel the robot may contribute to their care and how they respond to advice and education provided by the robot.
Subjects And Methods:
A humanoid robot was used in clinic and its acceptability was tested over 3 months in 37 children (aged 6-16 years) with type 1 diabetes during their clinic visits.
Results:
The obtained result showed that the overall patients' acceptability is 86.7%. However, the level of acceptability varies depending on the age group; patients aged 6-9 years showed the highest acceptability level of 94.8%, while the older age groups, 10-12 and 13-16 years, showed lower acceptability levels of 85.0% and 83.0%, respectively. There was no difference in the overall acceptability of the robot between the male and female patients (87.0% and 86.5%, respectively). Furthermore, features of the robot that were highly desirable include ability of the robot to give advice on high/low blood glucose (BG) levels (92.0%), how much the patients like the robot (91.4%), and ability of the robot to give advice on BG patterns (90.6%). In contrast, some other features were found least acceptable such as how likely patients want the robot as a companion (81.0%) and calculation of insulin doses with meals (82.53%). Analysis of variance across the responses of different age groups showed that P-value = 0.00003.
Conclusion:
Use of robots as a new device to support diabetes self-management in children was well accepted by patients.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Oral Hypoglycemic Agents: Biguanides and Glitazones

